![](/img/cover-not-exists.png)
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)
Massie, B. M., Berk, M. R., Brozena, S. C., Elkayam, U., Plehn, J. F., Kukin, M. L., Packer, M., Murphy, B. E., Neuberg, G. W., Steingart, R. M.Volume:
88
Language:
english
Journal:
Circulation
DOI:
10.1161/01.CIR.88.2.492
Date:
August, 1993
File:
PDF, 2.17 MB
english, 1993